The present invention provides novel ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes which exhibit binding activity at the serotonin 1A receptor.
Isoxazole derivatives for the treatment of irritable bowel syndrome
申请人:ELI LILLY AND COMPANY
公开号:EP0579507A1
公开(公告)日:1994-01-19
Provided is a method of treating Irritable Bowel Syndrome (IBS) using a series of isoxazole derivatives that have both 5-HT1A agonist and M1 muscarinic activities, and formulations suitable therefor.
Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes
申请人:ELI LILLY AND COMPANY
公开号:EP0712837A2
公开(公告)日:1996-05-22
The present invention provides novel ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes which exhibit binding activity at the serotonin 1A receptor.